BackMetlife Overview
Metlife Inc

Metlife Target Price

Analysts' average 12-month price target for Metlife is $100.

Get informed when a big investor buys or sells

+ Follow

Share Price

$97.25

Average Target Price

$100.102.9% upside

10 analysts in the last 4 months

High: $111 | Low: $86

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-24Morgan StanleyBob Huang$11114.1% upsideOpen
2026-08-19Wells Fargo$10912.1% upsideOpen
2026-08-06Barclays$970.3% downsideOpen
2026-07-15Atlantic Equities$1035.9% upsideOpen
2026-07-10JefferiesSuneet Kamath$1035.9% upsideOpen
2026-07-08UBSMichael Ward$1058% upsideOpen
2026-07-07BarclaysAlex Scott$943.3% downsideOpen
2026-07-06Morgan Stanley$1035.9% upsideOpen
2026-06-24Piper Sandler$907.5% downsideOpen
2026-05-26Piper Sandler$8611.6% downsideOpen
2026-05-21Morgan StanleyBob Huang$934.4% downsideOpen
2026-05-12Wells Fargo$952.3% downsideOpen
2026-05-08Mizuho SecuritiesYaron Kinar$952.3% downsideOpen
2026-05-07BarclaysAlex Scott$934.4% downsideOpen
2026-04-13Mizuho SecuritiesYaron Kinar$934.4% downsideOpen
2026-04-09Evercore ISI$961.3% downsideOpen
2026-04-09UBS$1024.9% upsideOpen
2026-02-12Mizuho Securities$1002.8% upsideOpen
2026-02-10Evercore ISIThomas Gallagher$952.3% downsideOpen
2026-02-05UBS$980.8% upsideOpen
2026-01-14Mizuho Securities$1024.9% upsideOpen
2026-01-13Wells FargoElyse Greenspan$970.3% downsideOpen
2026-01-08UBS$943.3% downsideOpen
2026-01-08Barclays$907.5% downsideOpen
2026-01-06Evercore ISI$970.3% downsideOpen
2025-12-15Mizuho Securities$1013.9% upsideOpen
2025-12-15Morgan Stanley$1013.9% upsideOpen
2025-10-08Barclays$980.8% upsideOpen
2025-10-07Morgan StanleyBob Huang$970.3% downsideOpen
2025-09-19Piper SandlerJohn Barnidge$8413.6% downsideOpen
2025-09-15Wolfe ResearchTracy Benguigui$952.3% downsideOpen
2025-07-14Morgan StanleyBob Huang$980.8% upsideOpen
2025-04-02Piper SandlerJohn Barnidge$943.3% downsideOpen
2025-02-28Morgan Stanley$10912.1% upsideOpen
2024-10-02Piper SandlerJohn Barnidge$925.4% downsideOpen
2024-09-04BarclaysAlex Scott$916.4% downsideOpen
2024-08-01Bank of America SecuritiesJoshua Shanker$961.3% downsideOpen
2024-07-10Morgan StanleyBob Huang$8314.7% downsideOpen
2024-05-22Argus ResearchKevin Heal$8017.7% downsideOpen
2024-05-06Piper SandlerJohn Barnidge$8215.7% downsideOpen
2024-03-13CFRACatherine Seifert$7720.8% downsideOpen
2024-01-08Goldman SachsAlex Scott$8017.7% downsideOpen
2023-09-14Mizuho SecuritiesBrett Linzey$14549.1% upsideOpen
2023-02-02Morgan Stanley$907.5% downsideOpen
2023-01-10Morgan Stanley$889.5% downsideOpen
2023-01-09Goldman Sachs$7819.8% downsideOpen
2023-01-06J.P. Morgan$8017.7% downsideOpen
2022-12-09Jefferies$8215.7% downsideOpen
2022-11-17Morgan Stanley$8710.5% downsideOpen
2022-08-22Credit Suisse$7720.8% downsideOpen

Metlife (MET) FAQ

The latest target price for MET is $100. Investors often review this figure alongside Metlife's historical trend and sector peers before judging valuation or financial health.

Metlife trades near $97.25 while the consensus target sits at $100 (2.9% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting MET's target price ($100), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Metlife's target price against similar Finance names. You can also browse sector and industry screens on Stockcircle for a broader set of Finance companies and their key multiples and fundamentals.